Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 227,328,966 papers from all fields of science
Search
Sign In
Create Free Account
Carcinoma of peritoneum
Known as:
peritoneal carcinoma
National Institutes of Health
Create Alert
Alert
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2009
2009
Ectopic intra-abdominal fascioliasis
A. Öngören
,
A. Özkan
,
A. Demirel
,
H. Üstün
,
M. Dönmez
Turkish Journal of Medical Sciences
2009
Corpus ID: 34278523
Human fascioliasis, caused by Fasciola hepatica, is emerging as an important chronic zoonotic disease in many areas of the world…
Expand
Review
2007
Review
2007
Incidental MRI detection of BRCA1-related solitary peritoneal carcinoma during breast screening--A case report.
K. Hill
,
B. Rosen
,
P. Shaw
,
P. Causer
,
E. Warner
Gynecologic Oncology
2007
Corpus ID: 24002993
2007
2007
Weekly paclitaxel in the treatment of recurrent ovarian carcinoma.
L. Byrd
,
F. Thistlethwaite
,
A. Clamp
,
C. Ton
,
J. Hasan
,
G. Jayson
European Journal of Gynaecological Oncology
2007
Corpus ID: 26643753
PURPOSE To study the effect of weekly paclitaxel in the treatment of recurrent ovarian and peritoneal carcinoma. METHODS A…
Expand
2005
2005
A phase I/II trial of weekly topotecan and carboplatin in potentially platinum-sensitive relapsed ovarian and peritoneal carcinoma.
P. Rose
,
M. Smrekar
,
P. Haba
,
C. Visser
,
J. Beeler
Gynecologic Oncology
2005
Corpus ID: 36801327
2004
2004
Triplet combination of gemcitabine, carboplatin, and paclitaxel in previously treated, relapsed ovarian and peritoneal carcinoma: an experience in Taiwan.
Fu‐shing Liu
,
E. Ho
,
M. Hung
,
Sheau-Feng Hwang
,
Chien-Hsing Lu
,
Y. Ke
Gynecologic Oncology
2004
Corpus ID: 8371422
2004
2004
A preliminary report of a phase II study of weekly topotecan in platinum-sensitive recurrent ovarian and peritoneal carcinoma.
M. Rodriguez
,
M. Method
,
G. Lewandowski
,
L. Vaccarello
,
R. Ansari
Journal of Clinical Oncology
2004
Corpus ID: 32866246
5063 Background: Topotecan 1.5 mg/m2 on days 1 through 5 of a 21-day cycle is an established chemotherapeutic regimen for…
Expand
2003
2003
Peritoneal Carcinoma in a Male Patient
M. Jermann
,
P. Vogt
,
B. Pestalozzi
Oncology
2003
Corpus ID: 5544377
Peritoneal carcinoma is a rare primary tumor, described in the literature almost exclusively in women. This report describes our…
Expand
1997
1997
Nuclear overexpression of p53 protein does not correlate with gene mutation in primary peritoneal carcinoma.
N. Marchenko
,
U. Moll
Human Pathology
1997
Corpus ID: 20330443
Review
1996
Review
1996
Surgically documented responses to paclitaxel and cisplatin in patients with primary peritoneal carcinoma.
A. Menzin
,
J. Aikins
,
J. Wheeler
,
S. Rubin
Gynecologic Oncology
1996
Corpus ID: 24894682
Intra-abdominal carcinomatosis indistinguishable from ovarian cancer may occur after removal of the ovaries or in association…
Expand
Review
1996
Review
1996
Cytologic assessment before and after intraperitoneal hyperthermic chemotherapy for peritoneal carcinomatosis.
B. Loggie
,
R. Fleming
,
K. Geisinger
Acta Cytologica
1996
Corpus ID: 3375177
OBJECTIVE A phase I/II clinical trial of surgical cytoreduction combined with intraperitoneal hyperthermic chemotherapy (IPHC…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE